Filter by TypeClear Filters


Application notes (6)

Brochures (8)

Cayman Currents (2)

Guides (3)

Lab Wall Posters (4)

Monographs (4)

Scientific posters (6)

Webinars (12)

Filter by CategoryClear Filters


Forensic Chemistry & Toxicology (42)

Lipid Biochemistry (1)

Neuroscience (7)

Services (1)

Toxicology (1)
Displaying 1 - 25 of 45 Results

What's New With NPS: The Rise of Semi-synthetics Complicates the Picture

Webinars


The emergence of previously unencountered novel psychoactive substances (NPS) in adulterated tablets, vape cartridges, and other consumer-marketed products continues to push forensic chemists, forensic toxicologists, emergency medical responders, and regulatory agencies into unchartered territory. Adding complexity to this evolving landscape is the recent discovery of semi-synthetic compounds in consumer products — substances not typically found in nature or present in quantities that suggest synthetic laboratory production.

Donna Iula summarizes the novel substances of greatest concern across classes such as synthetic opioids, benzodiazepines, stimulants, and synthetic cannabinoids including the concerning rise of semi-synthetic opioid NPS derived from Kratom, which are extremely potent.

Presented as part of the CFSRE's 2026 Current Trends in Seized Drug Analysis Symposium.

Do you have a question or comment for the presenter? Let us know.

Creating Custom Cannabis CRM Mixtures: Forty-seven Phytocannabinoids, One HPLC Method

Application notes


The development of custom phytocannabinoid certified reference material (CRM) mixtures requires a robust method to resolve coeluting components. This study presents the development and validation of a method addressing the separation of 47 phytocannabinoid compounds.

Highlights:

  • Chromatography was run on 47 phytocannabinoid compounds (12 acid and 35 neutral).
  • Co-eluting neutral compounds were identified and segregated for the acceptable validation of an HPLC method. 
  • This method supports Cayman’s quick turn production of custom phytocannabinoid CRMs.

To cite this application note: Franckowski, R., Gregerson, M., Calati, K., et al. Creating Custom Cannabis CRM Mixtures: Forty-seven Phytocannabinoids, One HPLC Method. Application Note, Cayman Chemical (2025).

Download Copy (PDF)

Semi-Synthetic Cannabinoids: An Emerging NPS Overview and Case Study on In-Vitro Metabolism

Webinars


Semi-synthetic cannabinoids (SSCs) represent an emerging class of Novel Psychoactive Substances (NPSs) that are often advertised and sold as legal. SSCs can be described as partially synthetic materials that are derived from natural components of the Cannabis Sativa L. plant, such as Cannabidiol (CBD). New studies on the in-vivo and in-vitro metabolism of SSC’s, such as Δ10-THC, Δ6a,10a-THC, and HHC, are emerging, which detail the similarities and differences seen to natural phytocannabinoid like Δ9-THC.


Alicyn Stothard and Jonathon Bassman, synthetic organic chemists at Cayman Chemical, discuss the overall landscape of newly emerging SSCs and their metabolism, along with a case study utilizing LC/MS-based identification of putative in-vitro metabolites for the SSC’s Δ10-THC and Δ6a,10a-THC.

Presented as part of the CFSRE's 2025 Current Trends in Forensic Toxicology Symposium.

Do you have a question or comment for the presenter? Let us know.

The Shifting Synthetic Cannabinoid NPS Landscape

Webinars


The current wave of so-called ‘semi-synthetic cannabinoids’ are defined as molecules that are not fully synthetic, as in JWH-018 or AB-FUBINACA, nor are they naturally occurring, as in Δ9-THC. This new class of ‘semi-synthetic’ NPS (Novel Psychoactive Substances) are structurally phytocannabinoid-like in composition and are similar to Δ9-THC. Analytical labs, clinicians, and policy administrators have always struggled to keep pace with the ever-changing synthetic cannabinoid landscape while keeping detection methods and policies current with the latest molecules-of-the-moment.

Jeffrey Williams presents a summary of the current wave of NPS called ‘semi-synthetic cannabinoids’ which are complicating the NPS scene.

Presented as part of the CFSRE's 2025 Current Trends in Forensic Toxicology Symposium.

Do you have a question or comment for the presenter? Let us know.

Metabolic Profiling of the Semi-synthetic Tetrahydrocannabinols (THCs), Δ10-THC and Δ6a,10a-THC, Using Human Liver Microsomes and LC/MS

Webinars


The pharmacology of several naturally occurring phytocannabinoid constituents of Cannabis sativa L., such as Δ9-THC, has previously been studied and well-documented in the scientific literature. However, since the deregulation of hemp in the 2018 USDA Farm Bill, new semi-synthetic structurally related isomers, analogs, and homologs have emerged, presenting new chemical entities with unknown metabolic profiles.

Listen as Nathan Layle, a synthetic organic chemist at Cayman Chemical, discusses the LC/MS-based identification of putative in vitro metabolites of the semi-synthetic tetrahydrocannabinols Δ10-THC and Δ6a,10a-THC.

Presented as part of the 77th Annual Scientific Conference of the American Academy of Forensic Sciences.

Do you have a question or comment for the presenter? Let us know.

​NPS Snapshot: Semi-synthetic Cannabinoids

Guides


Semi-synthetic cannabinoids rapidly emerged in the United States in response to legislative reforms that loosened Cannabis restrictions. Often marketed as “legal” alternatives to Δ9-THC, semi-synthetic cannabinoids have been widely sought after for both medicinal and recreational purposes. This NPS Snapshot summarizes the structures of the various semi-synthetic cannabinoids as well as key historical dates and known pharmacology.

To cite this NPS snapshot: Williams, J.B. and Hering, K.W. ​NPS snapshot: semi-synthetic cannabinoids. Cayman Chemical (April 2025).
Download Copy (PDF)

Δ9-THC, Δ10-THC, and Δ6a,10a-THC: Cayman NPS Metabolism Monograph, Issue 3

Monographs


The goal of this monograph is to identify the probable metabolites of the newly emerging semi-synthetic cannabinoids Δ10-THC and Δ6a,10a-THC using human liver microsomes (HLMs) and high-resolution mass spectrometry. The metabolism of Δ9-THC with HLMs was also investigated to provide forensic toxicologists a comparative understanding of the key fragments needed for identification.

This monograph was updated on April 18th, 2025, to provide clarification on the interpretation of the (6aR,9R)-Δ10-THC metabolite at R.T. 14.16 minutes in Figure 8. 

To cite this monograph: Bassman, J.R., Layle, N.K., Gregerson, M.C., et al. Δ9-THC, Δ10-THC, and Δ6a,10a-THC. Cayman NPS Metabolism Monograph Issue 3 (2025). 

Download Copy (PDF)

Some Assembly Required: Emerging Synthetic Cannabinoids

Webinars


Following China's generic structural class ban of several sub-classes of synthetic cannabinoids in 2021, the NPS/designer-drug landscape continues to evolve to evade regulation. As new structural variations appear on the grey market, another new phenomenon is the emergence of 'DIY' semi-finished kits. These semi-finished kits provide the end-user with non-regulated precursors enabling the user to finish the synthesis themselves to the desired synthetic cannabinoid of choice. Because the end-user often does not have the appropriate engineering and quality controls in place, drug substances on the illicit market are commonly contaminated with unreacted chemical precursors.  Several of these tail-less penultimate precursors have been detected on the grey market since late 2021.

Listen in as Holly Pierzynski, Cayman's Manager of Forensic Novel Psychoactive Substance Research, discusses several emerging synthetic cannabinoids, their precursors, synthesis, and byproducts from the synthesis. This presentation also highlights Cayman's new application note, "GC Separation of ADB-BUTINACA from its precursor ADB-INACA". 

Presented as part of the 2024 Midwestern Association of Forensic Scientists Conference in Kansas City, Missouri.

Do you have a question or comment for the presenter? Let us know.

​GC Separation of ADB-BUTINACA from its Precursor ADB-INACA

Application notes


Key Features

  • Coelution of ADB-BUTINACA and its synthetic precursor ADB-INACA makes traditional GC-MS methods difficult for the quantification of these two novel psychoactive substances (NPS). Quantities of these synthetic cannabinoids are distorted if the testing methods are unable to resolve the two substances in analyzed samples.
  • A new GC method for the separation of ADB-BUTINACA from its precursor ADB-INACA offers a reliable and robust solution for identifying this DEA Schedule I compound.

To cite this application note: Pierzynski, H.G., Liu, J., Calati, K.B., et al. GC separation of ADB-BUTINACA from its precursor ADB-INACA. Application Note, Cayman Chemical (2024).

Download Copy (PDF)

Creating Custom Cannabis CRM Mixtures: Forty-seven Phytocannabinoids, One HPLC Method

Scientific posters


Production of certified reference materials (CRMs) is prescribed by the conformity assessment standard ISO 17034:2016. Creating multi-component mixtures can present arduous challenges to ensure these criteria are met. 

This poster addresses the challenges of separating 47 phytocannabinoids for method validation and the considerations for the stability of the final CRM solutions. 

Do you have a question or comment for the presenter? Let us know.

To cite this poster: Franckowski, R., Gregerson, M., Calati, K., et al. Creating custom Cannabis CRM mixtures: Forty-seven phytocannabinoids, one HPLC method. Poster presented at: The AOAC International Annual Meeting; August 23-28, 2024. Baltimore, MD.


Download Copy (PDF)

​Synthetic Cannabinoid NPS

Brochures


Stay current on emerging synthetic cannabinoid NPS with Cayman’s reference standards. Cayman works closely with the forensic community to identify illicit synthetic cannabinoids and produce reference standards for the early detection of NPS. Cayman offers additional tools for the identification of unknown compounds, including GC-MS unknown analysis assistance, mass spectrometry resources like the Cayman Spectral Library and GC-MS Drug Identification Tool, as well as our lab wall poster guides
Download Copy (PDF)

What’s New on the Designer Drug Scene: Synthetic Cannabinoids, Precursors, and More

Webinars


As an important partner to the forensic community, Cayman Chemical is dedicated to the research, development, and production of a wide variety of research/analytical tools.  It is our responsibility to monitor current trends and rapidly develop reference standards necessary for the early detection of NPS.  Listen as Holly Pierzynski, Cayman’s Manager of Forensic Novel Psychoactive Substance Research, discusses recent developments among several popular drug classes including new analogues that have appeared recently on the grey marketplace and reviews the emergence of synthetic precursors being sold for the non-legitimate production of opioids, benzodiazepines, and synthetic cannabinoids. 

Presented as part of the 2024 Current Trends in Seized Drug Analysis Symposium.

Read the Webinar Highlights for a quick overview of the key takeaways. 

Do you have a question or comment for the presenter? Let us know.

Intoxicating Hemp and Synthetic Cannabinoids: Insights into Lab Testing

Webinars


Intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing. The disparity in quality and safety between cannabinoid-containing products found in state-legal dispensaries and those available in gas stations or smoke shops is significant and concerning. Moreover, there's a general lack of awareness among lawmakers about the intricacies of laboratory testing and the distinctions between natural and synthetic cannabinoids.

Key Learning Outcomes: 
  • Learn more about various compounds like THC, THCa, THCP, THCjd, HHCP, and others. 
  • Understand the nuanced differences in testing requirements for products labeled as "hemp-derived" versus "Cannabis-derived." 
  • Examine the potential risks and public health and safety concerns associated with unregulated cannabinoid-containing products.
Hosted by the GMP Collective as part of the When Things Go Wrong series. 

​New Drug Monograph: CHO-4'Me-5'Br-FUBOXPYRA

Monographs


​In July 2021, China banned several common synthetic cannabinoid core scaffolds to control the manufacturing and trafficking of these substances. This NPS Discovery Monograph documents the first report of CHO-4'Me-5'Br-FUBOXPYRA, a novel synthetic cannabinoid possessing an alternative 2-oxopyridine core scaffold. Cayman and the CFSRE established the “OXPYRA” systematic naming convention to be structurally informative and parallel existing synthetic cannabinoid NPS nomenclature, such as the OXIZID and IATA class.

Download Copy (PDF)

​Cannabinoid Signaling

Brochures


The cannabinoid receptors CB1 and CB2 can be activated by endogenous, synthetic, and phytocannabinoids. Cayman Chemical offers a broad collection of assay kits, antibodies, and ligands to study these receptors and related enzymes.

Download Copy (PDF)

Isomers, Homologs, and Analogues of THC - Challenges for Identification and Separation of New Psychoactive Substances

Webinars


Loopholes in the 2018 Farm Bill legislation have led to an increase of psychoactive THC products within the marketplace. Listen as Jeffrey B. Williams, Manager of Phytocannabinoid R&D at Cayman Chemical, discusses isomers, homologs, and analogues of tetrahydrocannabinol. Learn about the structural differences of new psychoactive products that are appearing showing up in Cannabis and Cannabis-based products, as well as associated challenges in identification and separation of these substances. 

Presented as part of the 2023 Current Trends in Forensic Toxicology Symposium

Do you have a question or comment for the presenter? Let us know.

​Hexahydrocannabinols (HHCs)

Brochures


Hydrogenation of tetrahydrocannabinols (Δ8- or Δ9-THC) leads to formation of a mixture of hexahydrocannabinols (HHCs) comprised of the 9(S)- and 9(R)-HHC diastereomers. These compounds retain some psychoactivity but avoid classification as THCs as well as any THC-related regulations. Separation of the HHC diastereomers is possible by chromatography (HPLC, GC), but identity can only be confirmed with verified reference standards. Cayman offers fully characterized reference standards to aid in the correct identification and differentiation of hydrogenated phytocannabinoids.

Download Copy (PDF)

​New Drug Monograph: ADB-5'Br-BINACA (ADB-5'Br-BUTINACA)

Monographs


New synthetic cannabinoids continue to emerge in the recreational drug supply following the class-wide ban implemented by China in July 2021. This NPS Discovery Monograph documents the newly identified synthetic cannabinoid ADB-5'Br-BINACA (ADB-5'Br-BUTINACA) containing a brominated indazole core, confirmed using Cayman's reference standard. To avoid confusion with tail substituents, Cayman and the CFSRE have developed a revised naming convention for new synthetic cannabinoids containing core substituents, denoted by a prime (‘) designation placed in the middle of the name.

Download Copy (PDF)

Synthetic Cannabinoid News from 2021

Webinars


As an important partner to the forensic community, Cayman Chemical is dedicated to the research, development, and production of a wide variety of research and analytical tools. It is our responsibility to monitor current trends and rapidly develop standards necessary for the early detection of NPS. Listen as Robert Schelkun, a synthetic organic chemist in Cayman’s Forensic Chemistry Division, discusses recent developments in popular drug classes. 

Presented as part of the What’s New on the Designer Drug Scene: Synthetic Cannabinoids, Arylcyclohexylamines and Others Workshop from the 2022 Current Trends in Seized Drug Analysis Symposium. 

Do you have a question or comment for the presenter? Let us know.

Bringing Back the Oldies: A Review of Phencyclidine and Ketamine Analogues, their Naming, Pharmacology, and EI-MS Interpretation

Webinars


As an important partner to the forensic community, Cayman Chemical is dedicated to the research, development, and production of a wide variety of research and analytical tools. It is our responsibility to monitor current trends and rapidly develop standards necessary for the early detection of NPS. Listen as Danielle St. Germaine, a synthetic organic chemist in Cayman’s Forensic Chemistry Division, discusses new analogues that have appeared recently on the grey marketplace and addresses common naming. Her presentation will focus on common naming and EI-MS fragmentation of new phencyclidine and ketamine analogues. She will also present a quick snap shot of recent hallucinogen, stimulant, opioid, and benzodiazepine NPS observed from 2020-2021.

Presented as part of the What’s New on the Designer Drug Scene: Synthetic Cannabinoids, Arylcyclohexylamines and Others Workshop from the 2022 Current Trends in Seized Drug Analysis Symposium. 

Do you have a question or comment for the presenter? Let us know.

Synthesis, Development, and Naming of NPS Reference Materials

Webinars


The rapid introduction of novel and diverse psychoactive substances on the designer drug scene continues to pose a challenge. Listen as Dr. Donna Iula, Cayman’s Vice President of Forensic Chemistry, describes the challenges of staying on top of this evolving market and what goes into the production of authentic reference standards. She will also discuss some of the latest NPS developments with a particular emphasis on recent changes within the synthetic cannabinoid landscape. 


Do you have a question or comment for the presenter? Let us know.

​New Drug Monograph: ADB-FUBIATA

Monographs


Several new synthetic cannabinoids have recently emerged among the recreation drug supply internationally, seemingly as replacements after a synthetic cannabinoid class-wide ban implemented by China in July 2021 which included most traditional indole/indazole carboxamide structural scaffolds. This NPS Discovery Report documents the newly identified synthetic cannabinoid ADB-FUBIATA confirmed using Cayman's reference standard. Little to no information regarding ADB-FUBIATA is currently available, specifically regarding activity and potency. Scientists at Cayman Chemical and the CFSRE developed a name for this substance and plan for naming related analogs, using “ATA” to represent the acetamide linker compared to prior “CA” used for a traditional carboxamide linker. 
Download Copy (PDF)

​New Systematic Naming for Synthetic Cannabinoid “MDA-19” and Its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZID

Guides


Cayman Chemical and NPS Discovery at the Center for Forensic Science Research and Education (CFSRE) have developed new, more appropriate names to address the newly emergent “MDA-19” and its related analogs following the systematic convention typically used for synthetic cannabinoid nomenclature. Our scientists developed a new naming convention for the emerging “OXIZID” generation of synthetic cannabinoids. “OXIZID” represents the core/linker region of the synthetic cannabinoid structure. Like other synthetic cannabinoids, head and tail constituents are abbreviated following previously developed or understood schemes.
Download Copy (PDF)

HPLC Method to Differentiate Four THC Stereoisomers Formed from Δ9-THC Degradation: (6aR,9R)-Δ10-THC, (6aR,9S)-Δ10-THC, 9(R)-Δ6a,10a-THC, and 9(S)-Δ6a,10a-THC

Application notes


Key Features

  • Δ10-THC and Δ6a,10a-THC isomers produced from Δ9-THC degradation have stereochemical similarities that are challenging to differentiate.
  • Traditional reversed-phase (C18) HPLC analysis is not suitable for accurate determination of these isomers.
  • A method using a chiral HPLC column under normal-phase conditions offers reliable and robust identification of the four stereoisomers.
  • Use of a chiral HPLC stationary phase for characterization of these phytocannabinoid degradants is an essential tool for the determination of potency and safety.

To cite this application note: Williams, J.B., Calati, K.B., Hering, K.W., et al., HPLC method to differentiate four THC stereoisomers formed from Δ9-THC degradation: (6aR,9R)-Δ10-THC, (6aR,9S)-Δ10-THC, 9(R)-Δ6a,10a-THC, and 9(S)-Δ6a,10a-THC. Application Note, Cayman Chemical (2021).

Download Copy (PDF)

​Phytocannabinoid Known Unknowns

Webinars


Learn about exciting developments in the world of Cannabis testing with Cayman scientist, Jeffrey Williams. In this webinar Jeffrey discusses details about degradation pathways and phytocannabinoids. 

Hosted by Emerald Scientific as part of their webinar series.

Do you have a question or comment for the presenter? Let us know.
Displaying 1 - 25 of 45 Results